Published November 2001 | Version v1
Journal article

Parkinson's disease associated with impaired oxidative phosphorylation

  • 1. Ludwig Boltzmann Inst. for Research in Epilepsy and Neuromuscular Disorders and 2. Neurological Dept., Neurological Hospital Rosenhuegel, Vienna (Austria)
  • 2. Institute of Clinical Neurology, University of Vienna, Vienna (Austria)
  • 3. Radiological Dept., Municipal Hospital Lainz, Vienna (Austria)

Description

Parkinson's disease may be due to primary or secondary oxidative phosphorylation (OXPHOS) defects. In a 76-year-old man with Parkinson's disease since 1992, slightly but recurrently elevated creatine phosphokinase, recurrently elevated blood glucose, thickening of the left ventricular myocardium, bifascicular block and hypacusis were found. Cerebral MRI showed atrophy, periventricular demyelination, multiple, disseminated, supra- and infratentorial lacunas, and haemosiderin deposits in both posterior horns. Muscle biopsy showed typical features of an OXPHOS defect. Whether the association of Parkinson's disease and impaired OXPHOS was causative or coincidental remains unknown. Possibly, the mitochondrial defect acted as an additional risk factor for Parkinson's disease or the OXPHOS defect worsened the preexisting neurological impairments by a cumulative or synergistic mechanism. In conclusion, this case shows that Parkinson's disease may be associated with a mitochondrially or nuclearly encoded OXPHOS defect, manifesting as hypacusis, myopathy, axonal polyneuropathy, cardiomyopathy and recurrent subclinical ischaemic strokes and haemorrhages. (orig.)

Additional details

Publishing Information

Journal Title
Neuroradiology
Journal Volume
43
Journal Issue
11
Journal Page Range
p. 997-1000
ISSN
0028-3940
CODEN
NRDYAB